Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer

Cell Transplantation

Volumn 22, Issue 11, 2013, Pages 2079-2090

  Su, Weijun ^a   Wang, Lina ^a,b   Zhou, Manqian ^a,c   Liu, Ze ^a   Hu, Shijun ^d   Tong, Lingling ^a   Liu, Yanhua ^a   Fan, Yan ^a   Kong, Deling ^e   Zheng, Yizhou ^b   Han, Zhongchao ^b   Wu, Joseph C ^d   Xiang, Rong ^a   Li, Zongjin ^a,e  

^a NANKAI UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c TIANJIN PEOPLE'S HOSPITAL   (China)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NANKAI UNIVERSITY   (China)

Author keywords

Cancer therapy; Cellular vehicle; Endothelial cells (ECs); Human embryonic stem cells (hESCs); Molecular imaging

Indexed keywords

BETA CATENIN; FIREFLY LUCIFERASE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; THYMIDINE KINASE; WNT PROTEIN; ANTIVIRUS AGENT; CULTURE MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BREAST CANCER CELL; BREAST METASTASIS; BYSTANDER EFFECT; CANCER CELL; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; EMBRYONIC STEM CELL DERIVED ENDOTHELIAL CELL; ENDOTHELIUM CELL; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMAGING; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; APOPTOSIS; BREAST NEOPLASMS; CELL LINE; CELL MOTION; CULTURE MEDIUM; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; LUNG NEOPLASMS; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHARMACOLOGY; SCID MOUSE; SECONDARY; SIMPLEXVIRUS; TRANSPLANTATION;

MUS; SIMPLEXVIRUS;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FEMALE; GANCICLOVIR; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 84886398979     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657927     Document Type: Article

References (35)

1. Aboody, K. S.; Najbauer, J.; Danks, M. K. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 15:739-752; 2008.
2. Cavarretta, I. T.; Altanerova, V.; Matuskova, M.; Kucerova, L.; Culig, Z.; Altaner, C. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol. Ther. 18:223-231; 2010.
3. Debatin, K. M.; Wei, J.; Beltinger, C. Endothelial progenitor cells for cancer gene therapy. Gene Ther. 15:780-786; 2008.
4. Giuffrida, D.; Rogers, I. M.; Nagy, A.; Calogero, A. E.; Brown, T. J.; Casper, R. F. Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth. Cell Prolif. 42:788-798; 2009.
5. Hamanishi, J.; Mandai, M.; Matsumura, N.; Baba, T.; Yamaguchi, K.; Fujii, S.; Konishi, I. Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer. Stem Cells 28:164-173; 2010.
6. Hu, W.; Wang, J.; Dou, J.; He, X.; Zhao, F.; Jiang, C.; Yu, F.; Hu, K.; Chu, L.; Li, X.; Gu, N. Augmenting therapy of ovarian cancer efficacy by secreting IL-21 human umbilical cord blood stem cells in nude mice. Cell Transplant. 20:669-680; 2011.
7. Janic, B.; Arbab, A. S. The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. Scientific World Journal 10:1088-1099; 2010.
8. Jiang, Z.; Teng, G. J.; Chen, B. A.; Xu, Z. F.; Hu, J.; Shao, Z. Y. Local effects of retrovirally transduced endostatin- expressing human umbilical cord blood CD34+ cells on transplanted malignancy in a mouse model of hepatic cancer. Cell Transplant. 17:969-975; 2008.
9. Karnoub, A. E.; Dash, A. B.; Vo, A. P.; Sullivan, A.; Brooks, M. W.; Bell, G. W.; Richardson, A. L.; Polyak, K.; Tubo, R.; Weinberg, R. A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563; 2007.
10. Kiely, B. E.; Soon, Y. Y.; Tattersall, M. H.; Stockler, M. R. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: A systematic review of recent randomized trials. J. Clin. Oncol. 29:456-463; 2011.
11. Li, Z.; Hu, S.; Ghosh, Z.; Han, Z.; Wu, J. C. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. Stem Cells Dev. 20:1701-1710; 2011.
12. Li, Z.; Suzuki, Y.; Huang, M.; Cao, F.; Xie, X.; Connolly, A. J.; Yang, P. C.; Wu, J. C. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26:864-873; 2008.
13. Li, Z.; Wilson, K. D.; Smith, B.; Kraft, D. L.; Jia, F.; Huang, M.; Xie, X.; Robbins, R. C.; Gambhir, S. S.; Weissman, I. L.; Wu, J. C. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One 4:e8443; 2009.
14. Liang, P. H.; Tian, F.; Lu, Y.; Duan, B.; Stolz, D. B.; Li, L. Y. Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors. Angiogenesis 14:61-68; 2010.
15. Lucas, T.; Abraham, D.; Untergasser, G.; Zins, K.; Hofer, E.; Gunsilius, E.; Aharinejad, S. Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice. Stem Cells 27:2342-2352; 2009.
16. Melero-Martin, J. M.; Dudley, A. C. Concise review: Vascular stem cells and tumor angiogenesis. Stem Cells 29:163-168; 2010.
17. Moon, S. H.; Kim, J. S.; Park, S. J.; Lee, H. J.; Do, J. T.; Chung, H. M. A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation. Biomaterials 32:6445-6455; 2011.
18. Moore, X. L.; Lu, J.; Sun, L.; Zhu, C. J.; Tan, P.; Wong, M. C. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther. 11:811-818; 2004.
19. Ping, Y.; Bian, X. Consice review: Contribution of cancer stem cells to neovascularization. Stem Cells 29:888-894; 2011.
20. Postovit, L.; Margaryan, N. V.; Seftor, E. A.; Kirschmann, D. A.; Lipavsky, A.; Wheaton, W. W.; Abbott, D. E.; Seftor, R. E. B.; Hendrix, M. J. C. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc. Natl. Acad. Sci. USA 105:4329-4334; 2008.
21. Purhonen, S.; Palm, J.; Rossi, D.; Kaskenpää, N.; Rajantie, I.; Ylä-Herttuala, S.; Alitalo, K.; Weissman, L. K.; Salven, P. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. USA 105:6620-6625; 2008.
22. Rad, A. M.; Iskander, A. S. M.; Janic, B.; Knight, R. A.; Arbab, A. S.; Soltanian-Zadeh, H. AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: A preliminary study. BMC Biotechnol. 9:28; 2009.
23. Reagan, M. R.; Kaplan, D. L. Concise review: Mesenchymal stem cell tumor-homing: Detection methods in disease model systems. Stem Cells 29:920-927; 2011.
24. Sasportas, L. S.; Kasmieh, R.; Wakimoto, H.; Hingtgen, S.; van de Water, J. A.; Mohapatra, G.; Figueiredo, J. L.; Martuza, R. L.; Weissleder, R.; Shah, K. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc. Natl. Acad. Sci. USA 106:4822-4827; 2009.
25. Stoll, B. R.; Migliorini, C.; Kadambi, A.; Munn, L. L.; Jain, R. K. A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: Implications for antiangiogenic therapy. Blood 102:2555-2561; 2003.
26. Suriano, R.; Chaudhuri, D.; Johnson, R. S.; Lambers, E.; Ashok, B. T.; Kishore, R.; Tiwari, R. K. 17b-Estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Res. 68:6038-6042; 2008.
27. Suva, L. J.; Griffin, R. J.; Makhoul, I. Mechanisms of bone metastases of breast cancer. Endocr. Relat. Cancer 16:703-713; 2009.
28. Tyler, M. A.; Ulasov, I. V.; Sonabend, A. M.; Nandi, S.; Han, Y.; Marler, S.; Roth, J.; Lesniak, M. S. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther. 16:262-278; 2009.
29. Vajkoczy, P.; Blum, S.; Lamparter, M.; Mailhammer, R.; Erber, R.; Engelhardt, B.; Vestweber, D.; Hatzopoulos, A. K. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J. Exp. Med. 197:1755-1765; 2003.
30. Wang, H.; Cao, F.; De, A.; Cao, Y.; Contag, C.; Gambhir, S. S.; Wu, J. C.; Chen, X. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 27:1548-1558; 2009.
31. Wang, L.; Su, W.; Liu, Z.; Zhou, M.; Chen, S.; Chen, Y.; Lu, D.; Liu, Y.; Fan, Y.; Zheng, Y.; Han, Z.; Kong, D.; Wu, J. C.; Xiang, R.; Li, Z. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. Biomaterials 33:5107-5114; 2012.
32. Wei, J.; Blum, S.; Unger, M.; Jarmy, G.; Lamparter, M.; Geishauser, A.; Vlastos, G. A.; Chan, G.; Fischer, K. D.; Rattat, D.; Debatin, K. M.; Hatzopoulos, A. K.; Beltinger, C. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 5:477-488; 2004.
33. Wei, J.; Jarmy, G.; Genuneit, J.; Debatin, K. M.; Beltinger, C. Human blood late outgrowth endothelial cells for gene therapy of cancer: Determinants of efficacy. Gene Ther. 14:344-356; 2007.
34. Wei, J.; Wahl, J.; Nakamura, T.; Stiller, D.; Mertens, T.; Debatin, K. M.; Beltinger, C. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas. Gene Ther. 14:1573-1586; 2007.
35. Zhou, M.; Wang, L.; Su, W.; Tong, L.; Liu, Y.; Fan, Y.; Luo, N.; Zheng, Y.; Zhao, H.; Xiang, R.; Li, Z. Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy. J. Biomed. Nanotechnol. 8:742-750; 2012.